Viewing Study NCT06892457


Ignite Creation Date: 2025-12-24 @ 6:55 PM
Ignite Modification Date: 2025-12-25 @ 4:28 PM
Study NCT ID: NCT06892457
Status: RECRUITING
Last Update Posted: 2025-03-24
First Post: 2025-03-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: PHArmacotherapy Assessed Using Neuroprobing With TransOsseal Magnetic Stimulation
Sponsor: Insel Gruppe AG, University Hospital Bern
Organization:

Study Overview

Official Title: PHArmacotherapy Assessed Using Neuroprobing With TransOsseal Magnetic Stimulation
Status: RECRUITING
Status Verified Date: 2025-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: PHANTOMS
Brief Summary: The goal of this observational study is to investigate how prescribed anti-seizure medications (ASMs) affect cortical excitability in adults with epilepsy. The main questions it aims to answer are:

1. Does the magnitude of transcranial magnetic stimulation (TMS)-evoked potentials (TEPs) measured with electroencephalography (EEG) change between OFF and ON medication states?
2. Do these changes in TEP amplitude persist over time? Researchers will compare each participant's measurements in the OFF state with those in the ON state to see if TEPs change following ASM (re)start.

Participants will undergo one TMS-EEG session scheduled around their prescribed ASM (re)start and one 1-6 months later.
Detailed Description: None

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: